Blood Transcript Biomarkers Selected by Machine Learning Algorithm Classify Neurodegenerative Diseases including Alzheimer’s Disease
Open Access
- 29 October 2022
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 12 (11) , 1592
Abstract
The clinical diagnosis of neurodegenerative diseases is notoriously inaccurate and current methods are often expensive, time-consuming, or invasive. Simple inexpensive and noninvasive methods of diagnosis could provide valuable support for clinicians when combined with cognitive assessment scores. Biological processes leading to neuropathology progress silently for years and are reflected in both the central nervous system and vascular peripheral system. A blood-based screen to distinguish and classify neurodegenerative diseases is especially interesting having low cost, minimal invasiveness, and accessibility to almost any world clinic. In this study, we set out to discover a small set of blood transcripts that can be used to distinguish healthy individuals from those with Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, Friedreich’s ataxia, or frontotemporal dementia. Using existing public datasets, we developed a machine learning algorithm for application on transcripts present in blood and discovered small sets of transcripts that distinguish a number of neurodegenerative diseases with high sensitivity and specificity. We validated the usefulness of blood RNA transcriptomics for the classification of neurodegenerative diseases. Information about features selected for the classification can direct the development of possible treatment strategies.Keywords
Funding Information
- NIH Ruth L. Kirschstein NRSA T32 Postdoctoral training grant (T32AG044402)
This publication has 42 references indexed in Scilit:
- β-Glucuronidase is a suitable internal control gene for mRNA quantitation in pathophysiological and non-pathological liversExperimental and Molecular Pathology, 2013
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersThe Lancet Neurology, 2013
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010Journal of Neuropathology & Experimental Neurology, 2012
- Alzheimer Mechanisms and Therapeutic StrategiesCell, 2012
- Probe mapping across multiple microarray platformsBriefings in Bioinformatics, 2011
- Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology, 2010
- Validation of suitable internal control genes for expression studies in agingMechanisms of Ageing and Development, 2010
- nuID: a universal naming scheme of oligonucleotides for Illumina, Affymetrix, and other microarraysBiology Direct, 2007
- [23] Random Forests for Microarrays2006
- Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s diseaseNeurobiology of Disease, 2003